🇺🇸 FDA
Patent

US 10849883

Benzopyrazole compounds and analogues thereof

granted A61KA61K31/416A61P

Quick answer

US patent 10849883 (Benzopyrazole compounds and analogues thereof) held by BioCryst Pharmaceuticals, Inc. expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/416, A61P, A61P13/00, A61P13/10